SBAC vs TARS · P/E 30, rev $1.42B vs rev $336.0M
SBA Communications Corp (SBAC) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
SBAC currently screens at market cap $24.58B and trailing P/E 30.3. TARS currently screens at market cap $2.66B.
Not investment advice. Open the SBAC and TARS stock pages for the full models.
Not investment advice.